Trial intelligence / Profile preview

RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease

NCT02838797Phase 1Completed

Sponsor
Virginia Commonwealth University
Start
Jun 2016
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of RQ-00000010 in gastroparesis and constipation (4 arms), sponsored by Virginia Commonwealth University. Primary endpoint: Number of Participants With Abnormal Laboratory Values and/or Adverse Events That Are Related to Treatment at 18 months. Started Jun 2016; status: completed.

02

Drugs

RQ-00000010
03

Conditions

gastroparesisconstipation

Beyond the preview

Go deeper on NCT02838797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02838797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call